AtheroNova filings

Related by string. * : AtheroNova . AtheroNova Operations Inc. / FILINGS . Filings : COMPANY 'S SEC FILINGS . Company periodic filings . heading SEC Filings . Facet Biotech filings . RR Donnelley filings . SEC filings . A. Schulman periodic filings . foreclosure filings . SEC Filings . filings . Tessera filings . Biophan periodic filings . Radware filings . Teledyne Technologies periodic filings * *

Related by context. Frequent words. (Click for all words.) 54 theSecurities 52 Securities andExchange Commission 51 risks anduncertainties 51 commercialization 50 Form #KSB 49 ExchangeCommission 48 Form 8K 48 TOCOSOL Paclitaxel 48 BLA submission 48 IoGen 48 FavId 48 PMA submission 47 Neo Urinary Conduit 47 Hybridon 47 Guided Therapeutics 47 Poly ICR 47 periodic reports 46 MONOVISC 46 IND submission 46 Chemokine Therapeutics 46 Eligard R 45 Neuradiab 45 www.norsat.com 45 Rotarix R 45 KRYSTEXXA 45 Ventiv Health Inc. 45 InKine 45 ADVENTRX 45 www.sedar.com www.sedar.com 45 MultiCell 45 vernakalant oral 45 businesses visit www.penton.com 45 Endovasc 44 obtaining regulatory approvals 44 ComfortScan system 44 Symphony tCGM System 44 EPIX Pharmaceuticals 44 NovaDel 44 theforward looking 44 Genitope Corporation 44 www.emergentbiosolutions.com 44 JZP 6 44 Management Proxy Circular 44 Risk Factors section 44 ATryn ® 44 MOZOBIL 44 Form# K 44 BEMA Fentanyl 43 clinical trials 43 DRAXIS 43 Plenaxis R 43 OLEPTRO TM 43 French Autorite des 43 filings 43 http:/www.sedar.com/ 43 8K filing 43 DR Cysteamine 43 www.exelixis.com 43 http:/www.sedar.com 43 Company Prospectus dated 43 TOPIGEN 42 Jennerex 42 Acologix 42 Information Form AIF 42 Vitaros 42 Interpharm 42 Sernova 42 preclinical 42 autoimmune indications 42 therapeutic monoclonal antibodies 42 accompanying Management Discussion 42 governmental approvals 42 NEBIDO 42 Joint Proxy Statement 42 Company periodic filings 42 www.clearwire.com 42 SILENOR TM 42 commercialize 42 AnGes 41 prospectus supplement dated 41 Interim Filings 41 OFIRMEV 41 Joint Proxy Statement Prospectus 41 Allovectin 7 R 41 Transgene 41 Radware filings 41 www.uqm.com 41 Statement Prospectus 41 outlicensing 41 forward lookingstatements 41 http:/www.diodes.com 41 heading Risk Factors 41 section captioned Risk 41 sedar.com 41 uncertainties 41 Trizytek 41 Topical Interferon Alpha 2b 41 Exelbine 41 Inflazyme 40 Cobalamin 40 Form #Q

Back to home page